Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

BOSTON and LEXINGTON, Mass., Feb. 15, 2024 /PRNewswire/ -- The Defense Threat Reduction Agency's Joint Science and Technology Office for the Chemical and Biological Defense Program has awarded,...

Related Keywords

Boston ,Massachusetts ,United States ,Rebecca Kurnat ,Jennifer Wipf ,Twitter ,Adjuvant Development ,Nasdaq ,Saponiqx Inc ,Instagram ,Defense Consortium ,Defense Threat Reduction Agency ,Linkedin ,Exchange Commission ,Ginkgo Bioworks Inc ,Technology Office ,Agenus Inc ,Joint Science ,Biological Defense ,Vaccines Prototype ,Ginkgo Bioworks ,Generative Molecular Design ,Commercial Cell Engineering ,Adjuvant Development Candidate ,Looking Statements ,Risk Factors ,Quarterly Report ,Annual Report ,Markets ,